Gene · 4175
Papers2,153
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,153
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A scalable platform for efficient CRISPR-Cas9 chemical-genetic screens of DNA damage-inducing compounds. | Sci Rep | 2024 | 38291084 | PubTator, text mining | PubMed |
| Cow's Milk: A Benefit for Human Health? Omics Tools and Precision Nutrition for Lactose Intolerance Management. | Nutrients | 2024 | 38276558 | PubTator, text mining | PubMed |
| Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice. | Medicina (Kaunas) | 2024 | 38256428 | PubTator, text mining | PubMed |
| Expressions of HuR, Methyl-HuR and Phospho-HuR in Endometrial Endometrioid Adenocarcinoma Are Associated with Clinical Features. | Int J Mol Sci | 2024 | 38256026 | PubTator, text mining | PubMed |
| Adipose Stromal Cell-Derived Secretome Attenuates Cisplatin-Induced Injury In Vitro Surpassing the Intricate Interplay between Proximal Tubular Epithelial Cells and Macrophages. | Cells | 2024 | 38247813 | PubTator, text mining | PubMed |
| Heterogeneous Expression Patterns of the Minichromosome Maintenance Complex Members in Retinoblastoma Unveil Its Clinical Significance. | Invest Ophthalmol Vis Sci | 2024 | 38231525 | PubTator, text mining | PubMed |
| Elevated genetic risk for multiple sclerosis emerged in steppe pastoralist populations. | Nature | 2024 | 38200296 | PubTator, text mining | PubMed |
| The selection landscape and genetic legacy of ancient Eurasians. | Nature | 2024 | 38200293 | PubTator, text mining | PubMed |
| Transcriptome analysis of adenomyosis eutopic endometrium reveals molecular mechanisms involved in adenomyosis-related implantation failure and pregnancy disorders. | Reprod Biol Endocrinol | 2024 | 38195505 | PubTator, text mining | PubMed |
| Prognostic biomarker discovery based on proteome landscape of Chinese lung adenocarcinoma. | Clin Proteomics | 2024 | 38182978 | PubTator, text mining | PubMed |
| PSMD14 stabilizes estrogen signaling and facilitates breast cancer progression via deubiquitinating ERα. | Oncogene | 2024 | 38017133 | PubTator, text mining | PubMed |
| Schistosoma mansoni-Induced Oxidative Stress Triggers Hepatocellular Proliferation. | Cell Mol Gastroenterol Hepatol | 2024 | 37696392 | PubTator, text mining | PubMed |
| A Genetic Lab-on-Phone Test for Point-of-Care Diagnostic of Lactose Intolerance near Patient and in less than 90 Minutes. | J Appl Lab Med | 2024 | 37647590 | PubTator, text mining | PubMed |
| RNA Sequencing and Bioinformatics Analysis Reveals the Downregulation of DNA Replication Genes by Morindone in Colorectal Cancer Cells. | Appl Biochem Biotechnol | 2024 | 37642925 | PubTator, text mining | PubMed |
| Systematic analysis of expression and prognostic significance for MCM family in head and neck squamous cell carcinoma. | Histol Histopathol | 2024 | 37526267 | PubTator, text mining | PubMed |
| Hypoxia Induces Tumor-Derived Exosome SNHG16 to Mediate Nasopharyngeal Carcinoma Progression through the miR-23b-5p/MCM6 Pathway. | Appl Biochem Biotechnol | 2024 | 37119503 | PubTator, text mining | PubMed |
| PPM1D activity promotes the replication stress caused by cyclin E1 overexpression. | Mol Oncol | 2024 | 37067201 | PubTator, text mining | PubMed |
| Global proteomics insights for a novel small compound targeting the non-integrin Laminin Receptor in a macrophage cell model. | Front Drug Discov (Lausanne) | 2023 | 41970647 | PubTator, text mining | PubMed |
| Progress in the treatment of lung adenocarcinoma by integrated traditional Chinese and Western medicine. | Front Med (Lausanne) | 2023 | 38259856 | PubTator, text mining | PubMed |
| Crowdsourcing temporal transcriptomic coronavirus host infection data: Resources, guide, and novel insights. | Biol Methods Protoc | 2023 | 38107402 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4175/papers?page=5